---
title: "Forum Markets, Incorporated (FRMM.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/FRMM.US.md"
symbol: "FRMM.US"
name: "Forum Markets, Incorporated"
industry: "Biotechnology"
datetime: "2026-05-20T06:25:10.409Z"
locales:
  - [en](https://longbridge.com/en/quote/FRMM.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/FRMM.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/FRMM.US.md)
---

# Forum Markets, Incorporated (FRMM.US)

## Company Overview

Forum Markets, Incorporated, a financial technology company, develops a blockchain-based platform focused on the acquisition, structuring, and tokenization of real-world assets worldwide. The company facilitates decentralized finance (DeFi) transactions and asset digitization across multiple Layer 2 Ethereum networks. It also provides tokenization solutions, DeFi protocol integration, blockchain analytics, traditional-to-digital asset conversion gateways, and other DeFi services. In addition, the company engages in native and liquid staking activities on the Ethereum blockchain.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.forum-markets.com](https://www.forum-markets.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: D (0.60)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 283 / 386 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.00% |  |
| Net Profit YoY | -3287.88% |  |
| P/B Ratio | 0.34 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 57279865.62 |  |
| Revenue | 9406000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -589.75% | E |
| Profit Margin | -5575.33% | E |
| Gross Margin | 100.00% | A |
| Revenue YoY | 0.00% | D |
| Net Profit YoY | -3287.88% | E |
| Total Assets YoY | 1681.95% | A |
| Net Assets YoY | 2084.60% | A |
| Cash Flow Margin | 8.70% | D |
| OCF YoY | 0.00% | D |
| Turnover | 0.09 | E |
| Gearing Ratio | 18.92% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Forum Markets, Incorporated",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-3287.88%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.34",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "57279865.62",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "9406000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-589.75%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-5575.33%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "100.00%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-3287.88%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "1681.95%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "2084.60%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "8.70%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.09",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "18.92%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.11 | 78/386 | - | - | - |
| PB | 0.34 | 20/386 | 0.39 | 0.18 | 0.13 |
| PS (TTM) | 6.09 | 127/386 | 14.83 | 13.37 | 7.35 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Kiniksa Pharmaceuticals (KNSA.US) | B | A | A | B | A | A |
| 02 | Arbutus Pharma (ABUS.US) | A | A | A | A | B | A |
| 03 | Rigel Pharma (RIGL.US) | A | A | B | A | B | A |
| 04 | Spero Therap (SPRO.US) | A | A | B | A | B | A |
| 05 | CapForce Inc. (CFOR.US) | B | A | A | A | B | A |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.11 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/FRMM.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/FRMM.US/norm.md)
- [Related News](https://longbridge.com/en/quote/FRMM.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/FRMM.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**